IndraLab

Statements



reach
"Silencing OTUD6B or LIN28B inhibits multiple myeloma outgrowth in vivo and high OTUD6B expression evolves in patients that progress to symptomatic multiple myeloma and results in an adverse outcome of the disease."

reach
"One study found that OTUD6B drives the G1/S transition and promotes the proliferation of multiple myeloma cells by suppressing microRNA biogenesis via LIN28B stabilization [ 11 ]."